Gold prices have recovered to the $4,000 level after a recent sharp selloff, but strategist Michele Schneider warns that the market still faces significant technical challenges. Despite ongoing inflation and geopolitical risks, gold's traditional safe-haven status appears weakened, with investors favoring U.S. government bonds due to falling yields. Schneider highlights a critical support level at $3,940; a drop below this could lead to a deeper correction toward $3,500 or even $2,500. She advises caution and risk management for any bullish positions and sees silver as weak, potentially attractive only if it falls another $15 to around $35 an ounce.
Gold's recovery above $4,000 provides context for market conditions. For readers following the broader US stock market, here is Pluang's market snapshot as of Nov 05, 2026 01:21 WIB: out of 150 priced US stocks, 121 rose and 29 fell. Notable movers include Carvana Co (CVNA) at USD 78.37 with a 9.95% increase and a typical hold time of 28 days, 3M Company (MMM) at USD 194.37 up 9.78% with a 170-day hold time, and Newmont Corporation (NEM) at USD 116.99 rising 8.86% with a 60-day hold time.
Goldman Sachs Group, Inc. disclosed that it briefly held a combined stake exceeding 3% in Ontex Group NV shares as of October 27, 2026, with 566,115 voting rights and 1,965,157 financial instruments. However, by October 28, 2026, their combined posit...
BNP Paribas announced its monthly declaration of voting rights and shares as of October 31, 2026. The bank reported a total of 1,101,600,607 shares and an equal number of voting rights. This update is part of regulatory compliance under French commer...
Ontex disclosed that Goldman Sachs Group, Inc. crossed the 3% ownership threshold in Ontex shares on October 27, 2026, holding a combined total of 3.07% including voting rights and financial instruments. However, the next day, October 28, 2026, Goldm...
Neion Bio has appointed John A. Maga, Ph.D., as Head of Biologics and CMC to lead the development of biologic medicines using its Raptor platform, which produces proteins in transgenic chicken eggs. Maga brings over 25 years of biopharmaceutical expe...
The National Advertising Division (NAD) recommended that Good Life Meds discontinue claims about health benefits and personalization for its compounded Tirzepatide+ weight loss products after a challenge by Eli Lilly. NAD found that Good Life lacked ...
